Michelle D van den Beukel

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Ankylosing Spondylitis

Disease Activity

Randomized Controlled Trial

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, Nicole V Borggreven, Thomas Wj Huizinga, Annette H M van der Helm van Mil, René E M Toes, Diane van der Woude, Leendert Adrianus Trouw
Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association. RMD open 9 (4) (2023)
Catherine D Hughes, Sarah E Ryan, Kathryn J A Steel, Michelle D van den Beukel, Leendert Adrianus Trouw, Karin A J van Schie, René E M Toes, Bina Menon, Bruce W Kirkham, Leonie S Taams
Type 17-specific immune pathways are active in early spondyloarthritis. RMD open 9 (4) (2023)
Catherine D Hughes, Sarah E Ryan, Kathryn J A Steel, Michelle D van den Beukel, Leendert Adrianus Trouw, Karin A J van Schie, René E M Toes, Bina Menon, Bruce W Kirkham, Leonie S Taams
Type 17-specific immune pathways are active in early spondyloarthritis. RMD open 9 (4) (2023)
Catherine D Hughes, Sarah E Ryan, Kathryn J A Steel, Michelle D van den Beukel, Leendert Adrianus Trouw, Karin A J van Schie, René E M Toes, Bina Menon, Bruce W Kirkham, Leonie S Taams
Type 17-specific immune pathways are active in early spondyloarthritis. RMD open 9 (4) (2023)
Rory Caitlin Monahan, Michelle D van den Beukel, Nicole V Borggreven, Rolf Fronczek, Thomas Wj Huizinga, Margreet Kloppenburg, Gerda M Steup-Beekman, Leendert Adrianus Trouw
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations. RMD open 8 (1) (2022)